Johnson & Johnson Announces Stock Repurchase Program
On January 22, 2002 Johnson & Johnson announced sales and earnings for the fiscal year 2001. Sales of $33 billion and net earnings, excluding special charges, of $5.9 billion increased by 10.6% and 18%, respectively, over the year 2000.
Johnson & Johnson adjusted average shares outstanding at year-end 2001 were 3,099.3 million on a diluted basis.
Most read news
Organizations
Other news from the department business & finance
Get the chemical industry in your inbox
By submitting this form you agree that LUMITOS AG will send you the newsletter(s) selected above by email. Your data will not be passed on to third parties. Your data will be stored and processed in accordance with our data protection regulations. LUMITOS may contact you by email for the purpose of advertising or market and opinion surveys. You can revoke your consent at any time without giving reasons to LUMITOS AG, Ernst-Augustin-Str. 2, 12489 Berlin, Germany or by e-mail at revoke@lumitos.com with effect for the future. In addition, each email contains a link to unsubscribe from the corresponding newsletter.